APO Research
Talk to an analyst

APO RESEARCH · REPORT

Osteoarthritis Autologous Chondrocyte Therapy

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Osteoarthritis Autologous Chondrocyte Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

26 December 2025175 pages

Choose your research edition.

Industry ResearchOsteoarthritis Autologous Chondrocyte Therapy Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Osteoarthritis Autologous Chondrocyte Therapy Industry Growth and Trends Forecast to 203263 pages · $3,450 USDMarket StructureGlobal Osteoarthritis Autologous Chondrocyte Therapy Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Osteoarthritis Autologous Chondrocyte Therapy Market Outlook and Growth Opportunities 2026192 pages · $4,250 USDMarket Analysis & ForecastGlobal Osteoarthritis Autologous Chondrocyte Therapy Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Osteoarthritis Autologous Chondrocyte Therapy market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for Osteoarthritis Autologous Chondrocyte Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Osteoarthritis Autologous Chondrocyte Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Osteoarthritis Autologous Chondrocyte Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Osteoarthritis Autologous Chondrocyte Therapy is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Osteoarthritis Autologous Chondrocyte Therapy include CO.DON GmbH, Japan Tissue Engineering, Orthocell and Vericel, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global Osteoarthritis Autologous Chondrocyte Therapy market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Osteoarthritis Autologous Chondrocyte Therapy and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Osteoarthritis Autologous Chondrocyte Therapy revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Osteoarthritis Autologous Chondrocyte Therapy market size, projected growth trends, production technologies, key applications, and end-use industries.

Osteoarthritis Autologous Chondrocyte Therapy Segment by Company

CO.DON GmbH

Japan Tissue Engineering

Orthocell

Vericel

Osteoarthritis Autologous Chondrocyte Therapy Segment by Type

2nd Gen C-ACI

3rd Gen M-ACI

Osteoarthritis Autologous Chondrocyte Therapy Segment by Application

Primary Osteoarthritis

Secondary Osteoarthritis

Osteoarthritis Autologous Chondrocyte Therapy Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Osteoarthritis Autologous Chondrocyte Therapy market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Osteoarthritis Autologous Chondrocyte Therapy and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Osteoarthritis Autologous Chondrocyte Therapy.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Osteoarthritis Autologous Chondrocyte Therapy in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Osteoarthritis Autologous Chondrocyte Therapy industry.

Chapter 3: Detailed analysis of Osteoarthritis Autologous Chondrocyte Therapy companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Osteoarthritis Autologous Chondrocyte Therapyrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of 2nd Gen C-ACI Table 3. Key Players of 3rd Gen M-ACI Table 4. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Primary Osteoarthritis Table 6. Key Players of Secondary Osteoarthritis Table 7. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 8. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size by Region (2021-2026) & (US$ Million) Table 9. Global Osteoarthritis Autologous Chondrocyte Therapy Market Share by Region (2021-2026) Table 10. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size by Region (2027-2032) & (US$ Million) Table 11. Global Osteoarthritis Autologous Chondrocyte Therapy Market Share by Region (2027-2032) Table 12. Osteoarthritis Autologous Chondrocyte Therapy Industry Trends Table 13. Osteoarthritis Autologous Chondrocyte Therapy Industry Drivers Table 14. Osteoarthritis Autologous Chondrocyte Therapy Industry Opportunities and Challenges Table 15. Osteoarthritis Autologous Chondrocyte Therapy Industry Restraints Table 16. Global Osteoarthritis Autologous Chondrocyte Therapy Revenue by Company (US$ Million) & (2021-2026) Table 17. Global Osteoarthritis Autologous Chondrocyte Therapy Revenue Market Share by Company (2021-2026) Table 18. Global Osteoarthritis Autologous Chondrocyte Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 19. Global Osteoarthritis Autologous Chondrocyte Therapy Key Company Head Office and Area Served Table 20. Global Osteoarthritis Autologous Chondrocyte Therapy Company, Product Type & Application Table 21. Global Osteoarthritis Autologous Chondrocyte Therapy Company Establishment Date Table 22. Global Company Market Concentration Ratio (CR5 and HHI) Table 23. Global Osteoarthritis Autologous Chondrocyte Therapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 24. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2021-2026) & (US$ Million) Table 26. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2027-2032) & (US$ Million) Table 27. Global Osteoarthritis Autologous Chondrocyte Therapy Revenue Market Share by Type (2021-2026) Table 28. Global Osteoarthritis Autologous Chondrocyte Therapy Revenue Market Share by Type (2027-2032) Table 29. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2021-2026) & (US$ Million) Table 31. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2027-2032) & (US$ Million) Table 32. Global Osteoarthritis Autologous Chondrocyte Therapy Revenue Market Share by Application (2021-2026) Table 33. Global Osteoarthritis Autologous Chondrocyte Therapy Revenue Market Share by Application (2027-2032) Table 34. CO.DON GmbH Company Information Table 35. CO.DON GmbH Business Overview Table 36. CO.DON GmbH Osteoarthritis Autologous Chondrocyte Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. CO.DON GmbH Osteoarthritis Autologous Chondrocyte Therapy Product Portfolio Table 38. CO.DON GmbH Recent Development Table 39. Japan Tissue Engineering Company Information Table 40. Japan Tissue Engineering Business Overview Table 41. Japan Tissue Engineering Osteoarthritis Autologous Chondrocyte Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. Japan Tissue Engineering Osteoarthritis Autologous Chondrocyte Therapy Product Portfolio Table 43. Japan Tissue Engineering Recent Development Table 44. Orthocell Company Information Table 45. Orthocell Business Overview Table 46. Orthocell Osteoarthritis Autologous Chondrocyte Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Orthocell Osteoarthritis Autologous Chondrocyte Therapy Product Portfolio Table 48. Orthocell Recent Development Table 49. Vericel Company Information Table 50. Vericel Business Overview Table 51. Vericel Osteoarthritis Autologous Chondrocyte Therapy Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Vericel Osteoarthritis Autologous Chondrocyte Therapy Product Portfolio Table 53. Vericel Recent Development Table 54. North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2021-2026) & (US$ Million) Table 55. North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2027-2032) & (US$ Million) Table 56. North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2021-2026) & (US$ Million) Table 57. North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2027-2032) & (US$ Million) Table 58. North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 59. North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2021-2026) Table 60. North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2027-2032) Table 61. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2021-2026) & (US$ Million) Table 62. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2027-2032) & (US$ Million) Table 63. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2021-2026) & (US$ Million) Table 64. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2027-2032) & (US$ Million) Table 65. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 66. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2021-2026) Table 67. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2027-2032) Table 68. China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2021-2026) & (US$ Million) Table 69. China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2027-2032) & (US$ Million) Table 70. China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2021-2026) & (US$ Million) Table 71. China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2027-2032) & (US$ Million) Table 72. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2021-2026) & (US$ Million) Table 73. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2027-2032) & (US$ Million) Table 74. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2021-2026) & (US$ Million) Table 75. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2027-2032) & (US$ Million) Table 76. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 77. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2021-2026) Table 78. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2027-2032) Table 79. South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2021-2026) & (US$ Million) Table 80. South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2027-2032) & (US$ Million) Table 81. South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2021-2026) & (US$ Million) Table 82. South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2027-2032) & (US$ Million) Table 83. South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 84. South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2021-2026) Table 85. South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2027-2032) Table 86. Research Programs/Design for This Report Table 87. Authors List of This Report Table 88. Secondary Sources Table 89. Primary Sources List of Figures Figure 1. Osteoarthritis Autologous Chondrocyte Therapy Product Image Figure 2. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type: 2025 VS 2032 Figure 4. 2nd Gen C-ACI Image Figure 5. 3rd Gen M-ACI Image Figure 6. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 7. Global Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application: 2025 VS 2032 Figure 8. Primary Osteoarthritis Image Figure 9. Secondary Osteoarthritis Image Figure 10. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 11. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 12. Global Osteoarthritis Autologous Chondrocyte Therapy Market Share by Region: 2025 VS 2032 Figure 13. Years Considered Figure 14. Global Osteoarthritis Autologous Chondrocyte Therapy Market Share by Players in 2025 Figure 15. Global Top 5 and 10 Osteoarthritis Autologous Chondrocyte Therapy Players Market Share by Revenue in 2025 Figure 16. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 17. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 18. Global Osteoarthritis Autologous Chondrocyte Therapy Revenue Market Share by Type (2021-2032) Figure 19. Global Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Osteoarthritis Autologous Chondrocyte Therapy Revenue Market Share by Application (2021-2032) Figure 21. North America Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 22. North America Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2021-2032) Figure 23. North America Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2021-2032) Figure 24. North America Osteoarthritis Autologous Chondrocyte Therapy Market Share by Country (2021-2032) Figure 25. United States Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 26. Canada Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 27. Mexico Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 28. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 29. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2021-2032) Figure 30. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2021-2032) Figure 31. Europe Osteoarthritis Autologous Chondrocyte Therapy Market Share by Country (2021-2032) Figure 32. Germany Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 33. France Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 34. U.K. Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 35. Italy Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 36. Russia Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 37. Nordic Countries Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 38. China Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 39. China Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2021-2032) Figure 40. China Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2021-2032) Figure 41. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 42. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2021-2032) Figure 43. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2021-2032) Figure 44. Asia Osteoarthritis Autologous Chondrocyte Therapy Market Share by Country (2021-2032) Figure 45. Japan Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 46. South Korea Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 47. Taiwan Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 48. Southeast Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 49. India Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 50. Australia Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 51. South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 52. South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2021-2032) Figure 53. South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2021-2032) Figure 54. South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Share by Country (2021-2032) Figure 55. Brazil Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 56. South Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 57. Saudi Arabia Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 58. Turkey Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 59. Argentina Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 60. UAE Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 61. Egypt Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 62. Chile Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032) & (US$ Million) Figure 63. Research Process Figure 64. Key Executives Interviewed

Scope & coverage.

Types
  • 2nd Gen C-ACI
  • 3rd Gen M-ACI
Applications
  • Primary Osteoarthritis
  • Secondary Osteoarthritis
Companies covered
  • CO.DON GmbH
  • Japan Tissue Engineering
  • Orthocell
  • Vericel

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global Osteoarthritis Autologous Chondrocyte Therapy Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 2nd Gen C-ACI
  5. 1.2.3 3rd Gen M-ACI
  6. 1.3 Market Analysis by Application
  7. 1.3.1 Global Osteoarthritis Autologous Chondrocyte Therapy Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  8. 1.3.2 Primary Osteoarthritis
  9. 1.3.3 Secondary Osteoarthritis
  10. 1.4 Global Market Growth Prospects
  11. 1.5 Global Osteoarthritis Autologous Chondrocyte Therapy Growth Trends by Region
  12. 1.5.1 Global Osteoarthritis Autologous Chondrocyte Therapy Market Size by Region: 2021 VS 2025 VS 2032
  13. 1.5.2 Osteoarthritis Autologous Chondrocyte Therapy Market Size by Region (2021-2026)
  14. 1.5.3 Osteoarthritis Autologous Chondrocyte Therapy Market Size by Region (2027-2032)
  15. 1.6 Assumptions and Limitations
  16. 1.7 Study Goals and Objectives
  17. 1.8 Years Considered
2 Global Osteoarthritis Autologous Chondrocyte Therapy Market Dynamics
  1. 2.1 Osteoarthritis Autologous Chondrocyte Therapy Industry Trends
  2. 2.2 Osteoarthritis Autologous Chondrocyte Therapy Industry Drivers
  3. 2.3 Osteoarthritis Autologous Chondrocyte Therapy Industry Opportunities and Challenges
  4. 2.4 Osteoarthritis Autologous Chondrocyte Therapy Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global Osteoarthritis Autologous Chondrocyte Therapy Revenue by Company (2021-2026)
  2. 3.2 Global Osteoarthritis Autologous Chondrocyte Therapy Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global Osteoarthritis Autologous Chondrocyte Therapy Key Company Head office and Area Served
  4. 3.4 Global Osteoarthritis Autologous Chondrocyte Therapy Company, Product Type & Application
  5. 3.5 Global Osteoarthritis Autologous Chondrocyte Therapy Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global Osteoarthritis Autologous Chondrocyte Therapy Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 Osteoarthritis Autologous Chondrocyte Therapy Players Market Share by Revenue in 2025
  9. 3.6.3 2025 Osteoarthritis Autologous Chondrocyte Therapy Tier 1, Tier 2, and Tier 3
4 Osteoarthritis Autologous Chondrocyte Therapy Market by Type
  1. 4.1 Global Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2021-2032)
  3. 4.3 Global Osteoarthritis Autologous Chondrocyte Therapy Market Size Share by Type (2021-2032)
5 Osteoarthritis Autologous Chondrocyte Therapy Market by Application
  1. 5.1 Global Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2021-2032)
  3. 5.3 Global Osteoarthritis Autologous Chondrocyte Therapy Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 CO.DON GmbH
  2. 6.1.1 CO.DON GmbH Company Information
  3. 6.1.2 CO.DON GmbH Business Overview
  4. 6.1.3 CO.DON GmbH Osteoarthritis Autologous Chondrocyte Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 CO.DON GmbH Osteoarthritis Autologous Chondrocyte Therapy Product Portfolio
  6. 6.1.5 CO.DON GmbH Recent Developments
  7. 6.2 Japan Tissue Engineering
  8. 6.2.1 Japan Tissue Engineering Company Information
  9. 6.2.2 Japan Tissue Engineering Business Overview
  10. 6.2.3 Japan Tissue Engineering Osteoarthritis Autologous Chondrocyte Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Japan Tissue Engineering Osteoarthritis Autologous Chondrocyte Therapy Product Portfolio
  12. 6.2.5 Japan Tissue Engineering Recent Developments
  13. 6.3 Orthocell
  14. 6.3.1 Orthocell Company Information
  15. 6.3.2 Orthocell Business Overview
  16. 6.3.3 Orthocell Osteoarthritis Autologous Chondrocyte Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Orthocell Osteoarthritis Autologous Chondrocyte Therapy Product Portfolio
  18. 6.3.5 Orthocell Recent Developments
  19. 6.4 Vericel
  20. 6.4.1 Vericel Company Information
  21. 6.4.2 Vericel Business Overview
  22. 6.4.3 Vericel Osteoarthritis Autologous Chondrocyte Therapy Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Vericel Osteoarthritis Autologous Chondrocyte Therapy Product Portfolio
  24. 6.4.5 Vericel Recent Developments
7 North America
  1. 7.1 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032)
  2. 7.2 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type
  3. 7.2.1 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2021-2026)
  4. 7.2.2 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2027-2032)
  5. 7.2.3 North America Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2021-2032)
  6. 7.3 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application
  7. 7.3.1 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2021-2026)
  8. 7.3.2 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2027-2032)
  9. 7.3.3 North America Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2021-2032)
  10. 7.4 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country
  11. 7.4.1 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2021-2026)
  13. 7.4.3 North America Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2027-2032)
  14. 7.4.4 North America Osteoarthritis Autologous Chondrocyte Therapy Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032)
  2. 8.2 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type
  3. 8.2.1 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2021-2026)
  4. 8.2.2 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2027-2032)
  5. 8.2.3 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2021-2032)
  6. 8.3 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application
  7. 8.3.1 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2021-2026)
  8. 8.3.2 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2027-2032)
  9. 8.3.3 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2021-2032)
  10. 8.4 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country
  11. 8.4.1 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2021-2026)
  13. 8.4.3 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2027-2032)
  14. 8.4.4 Europe Osteoarthritis Autologous Chondrocyte Therapy Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032)
  2. 9.2 China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type
  3. 9.2.1 China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2021-2026)
  4. 9.2.2 China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2027-2032)
  5. 9.2.3 China Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2021-2032)
  6. 9.3 China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application
  7. 9.3.1 China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2021-2026)
  8. 9.3.2 China Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2027-2032)
  9. 9.3.3 China Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032)
  2. 10.2 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type
  3. 10.2.1 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2021-2026)
  4. 10.2.2 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2027-2032)
  5. 10.2.3 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2021-2032)
  6. 10.3 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application
  7. 10.3.1 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2021-2026)
  8. 10.3.2 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2027-2032)
  9. 10.3.3 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2021-2032)
  10. 10.4 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country
  11. 10.4.1 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2021-2026)
  13. 10.4.3 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2027-2032)
  14. 10.4.4 Asia Osteoarthritis Autologous Chondrocyte Therapy Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type
  3. 11.2.1 South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application
  7. 11.3.1 South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country
  11. 11.4.1 South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa Osteoarthritis Autologous Chondrocyte Therapy Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst